EU MEDICINES AGENCY SAYS MARKETING AUTHORISATION FOR PFIZER VACCINE WOULD NEED TO BE AMENDED TO ALLOW EU-WIDE ADMINISTRATION OF SECOND DOSE MORE THAN 42 DAYS FROM FIRST